CompletedNot Applicable

Feasibility Pilot of Bright Light in the Intensive Care Unit

United States16 participantsStarted 2018-12-03

Plain-language summary

To evaluate the feasibility of providing daytime bright light in the ICU in a pilot randomized controlled trial.

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Hospital admission ≤30 hours at noon on enrollment day
✓. Expected to say in the Medical Intensive Care Unit ≥24 hours after enrollment
✓. Age ≥50 years
✓. History of hypertension based on chart review and presence of 1 or more home blood pressure medications
✓. Able to understand English

✕. At significant risk for pre-existing circadian abnormalities:
✕. Home medications include: melatonin, melatonin agonist
✕. Transferred from an outside hospital, long-term care, rehabilitation, or acute care facility
✕. History of bipolar disease (Bright light therapy possibly unsafe in this population).
✕. Paralyzed (due to injury, disease or medications)
✕. Diagnosed with hepatic encephalopathy in the setting of end-stage liver disease
✕. Homeless

Tolerance (Time): Percent of Intended Treatment Hours That Patient Continues With the Delivery of Bright Light

Timeframe: Study Day 2-5

NCT IDNCT03568045

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-31

Results submitted2024-05-21